Navigation Links
Resistant tumors could be treated with the discovery of a new molecule within cancer cells

A new research study published in the journal, Cancer Cell reported that scientists have discovered why some tumors respond less well to drug treatment as compared to others. Researchers have found that high levels of a specific molecule within cancer cells seem to block the effect of drugs such as Taxol, which are used to treat a number of cancers in their later stages. In the study, the// researchers focused on a molecule called AURORA-A which is found at higher than normal levels in up to half of breast and bowel tumors, and in many other kinds of cancer. They genetically engineered cervical cancer cells with the gene for AURORA-A in order to increase levels of the molecule. They found that when treated with Taxol only about half as many engineered cells were killed by the drug as non-engineered cells.

In normal cell division, a cell can only divide if it has correctly shared out all its genes, ensuring each new cell receives a complete set. If there is a problem with the process of sharing out genes, an alarm will be triggered and the cell will not divide. However, cells with high amounts of AURORA-A seemed to over-ride the alarm and continue to divide, even when their genes were not correctly shared out. This ability to ignore the alarm could make them resistant to Taxol-type drugs. Lead researcher, Ashok Venkitaraman said that high amounts of AURORA-A seemed to make cancer cells less sensitive to treatment and a new test to look for the molecules in the tumor to predict how effective Taxol treatment is likely to be. The findings that are yet to be confirmed in cancer patients, raises the additional possibility that new drugs which inactivate the molecule could boost the response of cancer cells to treatment.


'"/>




Page: 1

Related medicine news :

1. Hope for Chemo-Resistant Leukemia Patients
2. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
3. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
4. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
5. Resistant Influenza strains creates panic in US
6. Treatment Resistant Tumors Can Be Targeted Better Using Botox
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. ‘Drug Resistant TB’ Rattles the Union Ministy
9. Malaria Resistant Mosquitoes Could Help In Combating Malaria
10. Tumor Resistant Mice Point To Novel Cancer Treatments
11. Mad-Cow Resistant Calf Cloned in China
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... ... 2017 , ... The American Academy of Thermology ... and clinical application of medical infrared imaging, has announced two new educational offerings ... services. , The first new educational offering is an online self-directed Physician Member ...
(Date:5/22/2017)... NC (PRWEB) , ... May 22, 2017 , ... ... Matthews Periodontics, is now welcoming new patients with periodontal plastic surgery treatments, including ... from a general dentist. Dr. Green provides these esthetic and functional procedures to ...
(Date:5/22/2017)... ... ... An inventor from Columbia, S.C., wants to offer people with manual disabilities a ... firework accident, so she couldn’t grip a pen properly," he said. "This inspired me ... created a prototype for the HELPEN HAND, a special pen that enables a person ...
(Date:5/22/2017)... ... May 22, 2017 , ... Galena, Alaska, has a population of less than ... when it was targeted to build a nuclear plant by the TOSHIBA Corporation. , ... Marvin L. Yoder describes the journey to get power to his small town, off ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... May 15, 2017 Enterin Inc., a privately-held CNS ... developing novel compounds to treat Parkinson,s disease (PD), has enrolled ... a Phase 1/2a randomized, controlled, multicenter study involving patients with ... enroll 50 patients over a 9-to-12-month period. The first stage ... patients with PD. Participating sites include Denver ...
(Date:5/11/2017)... , May 11, 2017  Thornhill Research ... has been awarded an $8,049,024 USD five-year, firm-fixed-priced, ... through the Canadian Commercial Corporation (CCC) ( ... Anesthesia Systems to administer general anesthesia to patients ... "The US Marine Corps have been ...
Breaking Medicine Technology: